Abstract

Background

Children born very preterm (<32 weeks of gestation) face high risks of neurodevelopmental and health difficulties compared with children born at term. Follow-up after discharge from the neonatal intensive care unit is essential to ensure early detection and intervention, but data on policy approaches are sparse.

Methods

We investigated the characteristics of follow-up policy and programmes in 11 European countries from 2011 to 2022 using healthcare informant questionnaires and the published/grey literature. We further explored how one aspect of follow-up, its recommended duration, may be reflected in the percent of parents reporting that their children are receiving follow-up services at 5 years of age in these countries using data from an area-based cohort of very preterm births in 2011/12 (N = 3635).

Results

Between 2011/12 and 22, the number of countries with follow-up policies or programmes increased from 6 to 11. The policies and programmes were heterogeneous in eligibility criteria, duration and content. In countries that recommended longer follow-up, parent-reported follow-up rates at 5 years of age were higher, especially among the highest risk children, born <28 weeks’ gestation or with birthweight <1000 g: between 42.1% and 70.1%, vs. <20% in most countries without recommendations.

Conclusions

Large variations exist in follow-up policies and programmes for children born very preterm in Europe; differences in recommended duration translate into cross-country disparities in reported follow-up at 5 years of age.

Details

Title
Variation in follow-up for children born very preterm in Europe
Author
Seppänen, Anna-Veera 1   VIAFID ORCID Logo  ; Barros, Henrique 2   VIAFID ORCID Logo  ; Draper, Elizabeth S 3 ; Petrou, Stavros 4 ; Andronis, Lazaros 5 ; Kim, Sungwook 4 ; Maier, Rolf F 6 ; Pedersen, Pernille 7 ; Gadzinowski, Janusz 8 ; Pierrat, Véronique 1 ; Sarrechia, Iemke 9 ; Lebeer, Jo 9 ; Ådén, Ulrika 10 ; Toome, Liis 11 ; Thiele, Nicole 12 ; Arno van Heijst 13 ; Cuttini, Marina 14 ; Zeitlin, Jennifer 1   VIAFID ORCID Logo 

 Université de Paris Cité, Inserm, INRAE, Centre for Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Paediatric Epidemiology Research Team (EPOPé) , Paris, France 
 EPIUnit-Instituto de Saúde Pública da Universidade do Porto , Porto, Portugal 
 Department of Health Sciences, University of Leicester , Leicester, UK 
 Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford, UK 
 Division of Clinical Trials, Warwick Medical School, University of Warwick , Coventry, UK 
 Children’s Hospital, University Hospital, Philipps University Marburg , Marburg, Germany 
 Department of Neonatology, Hvidovre Hospital , Hvidovre, Denmark 
 Department of Neonatology, Poznan University of Medical Sciences , Poznan, Poland 
 Department of Family Medicine & Population Health, Faculty of Medicine & Health Sciences, University of Antwerp , Antwerp, Belgium 
10  Department of Women’s and Children’s Health, Karolinska Institutet , Stockholm, Sweden 
11  Department of Neonatal and Infant Medicine, Tallinn Children's Hospital , Tallinn, Estonia 
12  European Foundation for the Care of Newborn Infants (EFCNI) , Munich, Germany 
13  Department of Neonatology, Radboud University Medical Center , Nijmegen, The Netherlands 
14  Clinical Care and Management Innovation Research Area, Bambino Gesù Children’s Hospital, IRCCS , Rome, Italy 
Pages
91-100
Publication year
2024
Publication date
Feb 2024
Publisher
Oxford University Press
ISSN
11011262
e-ISSN
1464-360X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3192270897
Copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.